A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects (Q33893218)

29 July 2017

A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects (English)

1 reference

29 July 2017

0 references

Térouanne B

1

1 reference

29 July 2017

Tahiri B

2

1 reference

29 July 2017

Georget V

3

1 reference

29 July 2017

Belon C

4

1 reference

29 July 2017

Poujol N

5

1 reference

29 July 2017

Avances C

6

1 reference

29 July 2017

Orio F Jr

7

1 reference

29 July 2017

Balaguer P

8

1 reference

29 July 2017

Sultan C

9

1 reference

29 July 2017

1 February 2000

1 reference

Molecular and Cellular Endocrinology

29 July 2017

1 reference

29 July 2017

160

1 reference

29 July 2017

1-2

1 reference

29 July 2017

39-49

1 reference

Pharmacological profile of RU 58642, a potent systemic antiandrogen for the treatment of androgen-dependent disorders

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900251-8

7 January 2021

The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900251-8

7 January 2021

Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2).

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900251-8

7 January 2021

Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900251-8

7 January 2021

Different conversion metabolic rates of testosterone are associated to hormone-sensitive status and -response of human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900251-8

7 January 2021

Expression of different 17beta-hydroxysteroid dehydrogenase types and their activities in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900251-8

7 January 2021

Testosterone and 5 alpha-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT reporter gene

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900251-8

7 January 2021

Stable transfection of androgen receptor and MMTV-CAT into mammalian cells: inhibition of cat expression by anti-androgens

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900251-8

7 January 2021

Tiered screening and testing strategy for xenoestrogens and antiandrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900251-8

7 January 2021

Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900251-8

7 January 2021

Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900251-8

7 January 2021

Environmental antiandrogens: developmental effects, molecular mechanisms, and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900251-8

7 January 2021

Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900251-8

7 January 2021

Altered growth and insulin-like growth factor-binding protein-3 production in PC3 prostate carcinoma cells stably transfected with a constitutively active androgen receptor complementary deoxyribonucleic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900251-8

7 January 2021

Delta5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900251-8

7 January 2021

Mediation of glucocorticoid receptor function by transforming growth factor beta I expression in human PC-3 prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900251-8

7 January 2021

Comparison of in vitro effects of the pure antiandrogens OH-flutamide, Casodex, and nilutamide on androgen-sensitive parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900251-8

7 January 2021

Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900251-8

7 January 2021

Sexual differentiation and environmental endocrine disrupters.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900251-8

7 January 2021

Antiandrogenic effect of RU-486 in the mouse kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900251-8

7 January 2021

Characterization of polyclonal antibodies against the N-terminal domain of the human androgen receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900251-8

7 January 2021

Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900251-8

7 January 2021

Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900251-8

7 January 2021

10.1016/S0303-7207(99)00251-8

Identifiers

DOI

1 reference

29 July 2017

1 reference